Fil LTD Amgen Inc Transaction History

Fil LTD

$95.5 Billion
Q2 2024

A detailed history of Fil LTD transactions in Amgen Inc stock. As of the latest transaction made, Fil LTD holds 256,976 shares of AMGN stock, worth $81.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

256,976

Previous 289,067 11.1%

Holding current value

$81.2 Million

Previous $82.2 Million 2.31%

% of portfolio

0.08%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $8.43 Million - $10.2 Million	-32,091 Reduced 11.1%	256,976 $80.3 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $35.7 Million - $43.1 Million	-132,894 Reduced 31.49%	289,067 $82.2 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $25.5 Million - $28.8 Million	-99,704 Reduced 19.11%	421,961 $122 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $45.2 Million - $56.1 Million	206,567 Added 65.56%	521,665 $140 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $32.2 Million - $38.1 Million	150,391 Added 91.31%	315,098 $70 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $117 Million - $143 Million	-517,862 Reduced 75.87%	164,707 $39.8 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $53.5 Million - $68 Million	-233,800 Reduced 25.51%	682,569 $179 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $48.9 Million - $55.2 Million	-218,035 Reduced 19.22%	916,369 $207 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $11 Million - $12.2 Million	47,629 Added 4.38%	1,134,404 $276 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $13.5 Million - $14.9 Million	-61,627 Reduced 5.37%	1,086,775 $263 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $68.3 Million - $78.2 Million	-343,502 Reduced 23.02%	1,148,402 $258 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $58.6 Million - $68.6 Million	-275,970 Reduced 15.61%	1,491,904 $317 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $43.5 Million - $48.2 Million	-186,145 Reduced 9.53%	1,767,874 $431 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $244 Million - $285 Million	1,100,742 Added 129.0%	1,954,019 $486 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $123 Million - $146 Million	568,324 Added 199.44%	853,277 $196 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $2.27 Million - $2.52 Million	-9,662 Reduced 3.28%	284,953 $72.4 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $120,070 - $147,343	-607 Reduced 0.21%	294,615 $69.5 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $21.6 Million - $28.6 Million	-118,313 Reduced 28.61%	295,222 $59.9 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $15.8 Million - $20.3 Million	-83,632 Reduced 16.82%	413,535 $99.7 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $83 Million - $99.4 Million	476,689 Added 2327.81%	497,167 $96.2 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $183,036 - $214,560	-1,098 Reduced 5.09%	20,478 $3.77 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $31.5 Million - $35.5 Million	-173,908 Reduced 88.96%	21,576 $4.1 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $5.56 Million - $6.49 Million	-31,154 Reduced 13.75%	195,484 $38.1 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $30.2 Million - $34 Million	-162,817 Reduced 41.81%	226,638 $47 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $13.3 Million - $14.9 Million	-79,982 Reduced 17.04%	389,455 $71.9 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $4.21 Million - $4.92 Million	24,856 Added 5.59%	469,437 $80 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $6.16 Million - $6.88 Million	-36,480 Reduced 7.58%	444,581 $77.3 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $24.1 Million - $27.5 Million	-143,891 Reduced 23.02%	481,061 $89.7 Million
Q2 2017 Aug 29, 2017	BUY	N/A	624,952	624,952 $108 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account